Substance
ID:607
Names and Identifiers
Brand Name
Homatropine methyl bromideHumulon lead saltHycodan, probilagolNovatrinSed-temsSethylNpvatropineDL-Homatropine methyl bromideDL-MethylbromideHomatromideMethyl Bromide HomatropineMethylhomatropineMalcotranMesopinMethylhomatropine bromideNovatropineNovatrineTropinium methobromide mandelateArkitropinCamatropineEsopinHomapin
Synonyms
Homatropine Methylbromide
IUPAC Traditional name
(1R,3S,5S)-3-[(2-hydroxy-2-phenylacetyl)oxy]-8,8-dimethyl-8-azabicyclo[3.2.1]octan-8-ium bromide
IUPAC name
(1R,3S,5S)-3-[(2-hydroxy-2-phenylacetyl)oxy]-8,8-dimethyl-8-azabicyclo[3.2.1]octan-8-ium bromide
Registration numbers
CAS Number
Properties
Physical Property
Hydrophobicity(logP)
3.421
Molecule Details
Drug Groups
approved
Description
Homatropine methylbromide is a quaternary ammonium muscarinic acetylcholine receptor antagonist belonging to the group of medicines called anti-muscarinics. Homatropine is used to treat duodenal or stomach ulcers or intestine problems. It can be used together with antacids or other medicine in the treatment of peptic ulcer. It may also be used to prevent nausea, vomiting, and motion sickness.
Indication
Used in conjunction with antacids or histamine H2-receptor antagonists in the treatment of peptic ulcers, gastric ulcers and duodenal ulcers, to reduce further gastric acid secretion and delay gastric emptying.
Pharmacology
Homatropine methylbromide belongs to the group of medicines called anti-muscarinics. Homatropine is used to treat duodenal or stomach ulcers or intestine problems. It can be used together with antacids or other medicine in the treatment of peptic ulcer. It may also be used to prevent nausea, vomiting, and motion sickness.
Affected Organisms
Humans and other mammals
External Links
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data